EUVIMEDEUVIMED entdecken
Open Access

The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7

Marcia Bellon, Chien-Hung Yeh, Xue Tao Bai, Christophe Nicot iD

Journal of Virology · 2024

DOI: 10.1128/jvi.00405-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Marcia Bellon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, Human T-lymphotropic virus 1, Gene Products, tax, F-Box Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human T-cell leukemia virus type 1 (HTLV-I) is the etiological agent of adult T-cell leukemia (ATL). Mutational analysis has demonstrated that the tumor suppressor, F-box and WD repeat domain containing 7 (FBXW7/FBW7/CDC4), is mutated in primary ATL patients. However, even in the absence of genetic mutations, FBXW7 substrates are stabilized in ATL cells, suggesting additional mechanisms can prevent FBXW7 functions. Here, we report that the viral oncoprotein Tax represses FBXW7 activity, resulting in the stabilization of activated Notch intracellular domain, c-MYC, Cyclin E, and myeloid cell leukemia sequence 1 (BCL2-related) (Mcl-1). Mechanistically, we demonstrate that Tax directly binds to FBXW7 in the nucleus, effectively outcompeting other targets for binding to FBXW7, resulting in decreased ubiquitination and degradation of FBXW7 substrates. In support of the nuclear role of Tax, a non-degradable form of the nuclear factor kappa B subunit 2 (NFκB2/p100) was found to delocalize Tax to the cytoplasm, thereby preventing Tax interactions with FBXW7 and Tax-mediated inhibition of FBXW7. Finally, we characterize a Tax mutant that is unable to interact with FBXW7, unable to block FBXW7 tumor suppressor functions, and unable to effectively transform fibroblasts. These results demonstrate that HTLV-I Tax can inhibit FBXW7 functions without genetic mutations to promote an oncogenic state. These results suggest that Tax-mediated inhibition of FBXW7 is likely critical during the early stages of the cellular transformation process. IMPORTANCE F-box and WD repeat domain containing 7 (FBXW7), a critical tumor suppressor of human cancers, is frequently mutated or epigenetically suppressed. Loss of FBXW7 functions is associated with stabilization and increased expression of oncogenic factors such as Cyclin E, c-Myc, Mcl-1, mTOR, Jun, and Notch. In this study, we demonstrate that the human retrovirus human T-cell leukemia virus type 1 oncoprotein Tax directly interacts with FBXW7, effectively outcompeting other targets for binding to FBXW7, resulting in decreased ubiquitination and degradation of FBXW7 cellular substrates. We further demonstrate that a Tax mutant unable to interact with and inactivate FBXW7 loses its ability to transform primary fibroblasts. Collectively, our results describe a novel mechanism used by a human tumor virus to promote cellular transformation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

F-Box-WD Repeat-Containing Protein 7Human T-lymphotropic virus 1Gene Products, taxF-Box ProteinsCell Cycle ProteinsUbiquitin-Protein LigasesHumansProtein Binding

Stichwörter der Autor:innen

ATLCDC4Cyclin EFBXW7HTLVIKKMYCMcl-1NF-kBNotchTaxleukemia

Substanzen

F-Box-WD Repeat-Containing Protein 7FBXW7 protein, humanGene Products, taxF-Box ProteinsCell Cycle ProteinsUbiquitin-Protein Ligasestax protein, Human T-lymphotrophic virus 1

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

ORCID-Profile: Christophe Nicot

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • HHS | NIH | National Cancer Institute (NCI)

Zitieren

APA

Bellon, M., Yeh, C., Bai, X. T., & Nicot, C. (2024). The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7. Journal of Virology. https://doi.org/10.1128/jvi.00405-24

Vancouver

Bellon M, Yeh C, Bai XT, Nicot C. The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7. Journal of Virology. 2024. doi:10.1128/jvi.00405-24

BibTeX
@article{Bellon2024,
  author = {Bellon, Marcia and Yeh, Chien-Hung and Bai, Xue Tao and Nicot, Christophe},
  title = {The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.00405-24}
}
Kostenlos starten →